The pathophysiology associated with the development of immune thrombocytopenic purpura is the formation of IgG antibodies against platelets surface proteins like GPIIb-IIIa and GIb-IX; however, many unknown mechanisms need to be explored in the pathogenesis of ITP [4]. This evidence concerns the gene PROS1 and autoimmune thrombocytopenic purpura.